BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gazerani P, Cairns BE. Sex-Specific Pharmacotherapy for Migraine: A Narrative Review. Front Neurosci 2020;14:222. [PMID: 32265634 DOI: 10.3389/fnins.2020.00222] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Brewerton TD, Perlman MM, Gavidia I, Suro G, Jahraus J. Headache, eating disorders, PTSD, and comorbidity: implications for assessment and treatment. Eat Weight Disord 2022. [PMID: 35604548 DOI: 10.1007/s40519-022-01414-6] [Reference Citation Analysis]
2 Viero FT, Rodrigues P, Frare JM, Da Silva NAR, Ferreira MDA, Da Silva AM, Pereira GC, Ferreira J, Pillat MM, Bocchi GV, Nassini R, Geppetti P, Trevisan G. Unpredictable Sound Stress Model Causes Migraine-Like Behaviors in Mice With Sexual Dimorphism. Front Pharmacol 2022;13:911105. [DOI: 10.3389/fphar.2022.911105] [Reference Citation Analysis]
3 Krause DN, Warfvinge K, Haanes KA, Edvinsson L. Hormonal influences in migraine - interactions of oestrogen, oxytocin and CGRP. Nat Rev Neurol 2021;17:621-33. [PMID: 34545218 DOI: 10.1038/s41582-021-00544-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gazerani P. A link between migraine and prolactin: the way forward. Future Sci OA 2021;7:FSO748. [PMID: 34737888 DOI: 10.2144/fsoa-2021-0047] [Reference Citation Analysis]
5 Spekker E, Tanaka M, Szabó Á, Vécsei L. Neurogenic Inflammation: The Participant in Migraine and Recent Advancements in Translational Research. Biomedicines 2022;10:76. [DOI: 10.3390/biomedicines10010076] [Reference Citation Analysis]
6 Migliore L, Nicolì V, Stoccoro A. Gender Specific Differences in Disease Susceptibility: The Role of Epigenetics. Biomedicines 2021;9:652. [PMID: 34200989 DOI: 10.3390/biomedicines9060652] [Reference Citation Analysis]
7 MaassenVanDenBrink A, Terwindt GM, Cohen JM, Barash S, Campos VR, Galic M, Ning X, Kärppä M. Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study. J Headache Pain 2021;22:152. [PMID: 34922436 DOI: 10.1186/s10194-021-01336-1] [Reference Citation Analysis]
8 Baser A, Eliaçık S, Baykam MM, Tan FU. Clinical Manifestations of Overactive Bladder With Migraine as a Comorbidity: A Prospective Cross-Sectional Study. Int Neurourol J 2020;24:375-81. [PMID: 33401359 DOI: 10.5213/inj.2040186.093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]